Cargando…

Editorial: HIV and Cancer Immunotherapy: Similar Challenges and Converging Approaches

Detalles Bibliográficos
Autores principales:	Paiardini, Mirko, Dhodapkar, Kavita, Harper, Justin, Deeks, Steven G., Ahmed, Rafi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138010/ https://www.ncbi.nlm.nih.gov/pubmed/32296432 http://dx.doi.org/10.3389/fimmu.2020.00519

Ejemplares similares

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
por: Costa, Federica, et al.
Publicado: (2018)

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
por: Dhodapkar, Madhav V., et al.
Publicado: (2019)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies
por: Huot, Nicolas, et al.
Publicado: (2018)

Role of Tissue-Resident Memory in Intra-Tumor Heterogeneity and Response to Immune Checkpoint Blockade
por: Dhodapkar, Kavita M.
Publicado: (2018)

Editorial: The challenge of immunity evaluation and immunotherapy in gynecologic and urologic oncology
por: Tan, Ruirong, et al.
Publicado: (2023)

Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention
por: McCachren, Samuel S., et al.
Publicado: (2021)

Editorial: Recent advances and challenges in cancer immunotherapies for patients with autoimmune diseases
por: Saleh, Reem
Publicado: (2023)

Editorial: Cytokine and cytokine receptor-based immunotherapies: Updates, controversies, challenges, and future perspectives
por: Wang, Jun, et al.
Publicado: (2022)

Editorial: Immunotherapy in Multiple Myeloma
por: Giuliani, Nicola, et al.
Publicado: (2019)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Macrophage Polarization: Convergence Point Targeted by Mycobacterium Tuberculosis and HIV
por: Lugo-Villarino, Geanncarlo, et al.
Publicado: (2011)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Editorial: Nanobody-based cancer immunotherapy and immunoimaging
por: Jafari, Mahdie, et al.
Publicado: (2023)

Editorial: Translational phenomics and its applications in immunotherapy
por: Fang, Hai, et al.
Publicado: (2023)

Editorial: Extracellular traps in cancer immunity and immunotherapy
por: Rahat, Michal A., et al.
Publicado: (2023)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023)

Editorial: Challenges in Vaccinology
por: Lavelle, Ed C., et al.
Publicado: (2020)

Immunotherapy in People With HIV and Cancer
por: Puronen, Camille E., et al.
Publicado: (2019)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
por: Chandra, Janin, et al.
Publicado: (2022)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Non-coding RNA in immunotherapies and immune regulation
por: Kaeffer, Bertrand, et al.
Publicado: (2022)

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
por: Feron, Olivier, et al.
Publicado: (2023)

Editorial: Novel biomarkers for predicting response to cancer immunotherapy
por: Huangfu, Shuchen, et al.
Publicado: (2023)

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
por: Maeurer, Markus
Publicado: (2023)

Editorial: Translation of genetically engineered T cells in cancer immunotherapy
por: Voss, Ralf-Holger, et al.
Publicado: (2023)

Editorial: Dual role of inflammatory mediators in cancer immunotherapy
por: Wang, Xiaoli, et al.
Publicado: (2023)

Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy
por: Porta, Chiara, et al.
Publicado: (2023)

Editorial: Rising stars in cancer immunity and immunotherapy 2022
por: Goyvaerts, Cleo, et al.
Publicado: (2023)

Immunotherapy for Glioblastoma: Current Progress and Challenges
por: Yu, Miranda W., et al.
Publicado: (2021)

Understanding and targeting inflammation in SARS-CoV-2 and HIV infections
por: Paiardini, Mirko
Publicado: (2022)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73noke0d8um3dsjir2r6p3imfc